ATE199087T1 - Substituierte tetracyclische azepinederivate mit 5-ht2 rezeptoraffinität - Google Patents

Substituierte tetracyclische azepinederivate mit 5-ht2 rezeptoraffinität

Info

Publication number
ATE199087T1
ATE199087T1 AT95937006T AT95937006T ATE199087T1 AT E199087 T1 ATE199087 T1 AT E199087T1 AT 95937006 T AT95937006 T AT 95937006T AT 95937006 T AT95937006 T AT 95937006T AT E199087 T1 ATE199087 T1 AT E199087T1
Authority
AT
Austria
Prior art keywords
receptor affinity
substituted tetracyclic
azepine derivatives
tetracyclic azepine
derivatives
Prior art date
Application number
AT95937006T
Other languages
English (en)
Inventor
Victor Karel Sipido
Francisco Javi Fernandez-Gadea
Jose Ignacio Andres-Gil
Theo Frans Meert
Pilar Gil-Lopetegui
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE199087T1 publication Critical patent/ATE199087T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95937006T 1994-11-02 1995-10-25 Substituierte tetracyclische azepinederivate mit 5-ht2 rezeptoraffinität ATE199087T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94203178 1994-11-02
US08/457,968 US5552399A (en) 1994-11-02 1995-05-31 Substituted tetracyclic azepine derivatives
PCT/EP1995/004196 WO1996014320A1 (en) 1994-11-02 1995-10-25 Substituted tetracyclic azepine derivatives which have affinity for 5-ht2 receptors

Publications (1)

Publication Number Publication Date
ATE199087T1 true ATE199087T1 (de) 2001-02-15

Family

ID=8217337

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95937006T ATE199087T1 (de) 1994-11-02 1995-10-25 Substituierte tetracyclische azepinederivate mit 5-ht2 rezeptoraffinität

Country Status (30)

Country Link
US (1) US5552399A (de)
EP (1) EP0789701B1 (de)
JP (1) JP3818541B2 (de)
KR (1) KR100392060B1 (de)
CN (1) CN1085667C (de)
AR (1) AR002238A1 (de)
AT (1) ATE199087T1 (de)
AU (1) AU704285B2 (de)
BR (1) BR9509552A (de)
CA (1) CA2203661A1 (de)
CZ (1) CZ286945B6 (de)
DE (1) DE69520070T2 (de)
DK (1) DK0789701T3 (de)
ES (1) ES2155898T3 (de)
FI (1) FI113050B (de)
GR (1) GR3035680T3 (de)
HR (1) HRP950537A2 (de)
HU (1) HUT77408A (de)
IL (1) IL115819A (de)
MY (1) MY113325A (de)
NO (1) NO308035B1 (de)
NZ (1) NZ295656A (de)
PL (1) PL183686B1 (de)
PT (1) PT789701E (de)
RU (1) RU2163240C2 (de)
SI (1) SI0789701T1 (de)
TR (1) TR199501356A2 (de)
TW (1) TW349950B (de)
WO (1) WO1996014320A1 (de)
ZA (1) ZA959215B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0892804T3 (da) * 1996-04-12 2002-12-02 Janssen Pharmaceutica Nv Isoxazolidin derivater
UA52778C2 (uk) 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20030885A2 (en) * 2003-11-03 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS
HRP20030953A2 (en) * 2003-11-21 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
US20110086086A1 (en) * 2005-07-26 2011-04-14 Pfizer Inc Transdermal system for varenicline
US11517557B2 (en) * 2017-07-13 2022-12-06 Tonix Pharmaceuticals Holding Corp. Analogs of cyclobenzaprine and amitriptyline

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT338799B (de) * 1974-03-02 1977-09-12 Boehringer Sohn Ingelheim Verfahren zur herstellung neuer substituierter 6-aryl-4h-s-triazolo-(3,4c)-thieno-(2,3e)-1,4-diazepine und ihrer salze
NL7414038A (nl) * 1974-10-28 1976-05-03 Akzo Nv Nieuwe tetracyclische pyrrolidino derivaten.
DE2647114A1 (de) * 1975-10-21 1977-05-05 Hans Fickler Vorrichtung zur erzeugung einer laengsbewegung
JPS5572177A (en) * 1978-11-27 1980-05-30 Shionogi & Co Ltd 4,1-benzoxazepine or 4,1-benzothiazepine
TW206227B (de) * 1989-10-05 1993-05-21 Sankyo Co
US5512563A (en) * 1993-07-29 1996-04-30 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists

Also Published As

Publication number Publication date
MY113325A (en) 2002-01-31
EP0789701A1 (de) 1997-08-20
ZA959215B (en) 1997-04-30
CN1162313A (zh) 1997-10-15
AR002238A1 (es) 1998-03-11
FI113050B (fi) 2004-02-27
PL183686B1 (pl) 2002-06-28
CZ132397A3 (cs) 1998-01-14
DE69520070D1 (de) 2001-03-15
WO1996014320A1 (en) 1996-05-17
IL115819A0 (en) 1996-01-19
FI971854A7 (fi) 1997-04-30
EP0789701B1 (de) 2001-02-07
MX9703255A (es) 1997-07-31
RU2163240C2 (ru) 2001-02-20
PT789701E (pt) 2001-07-31
CN1085667C (zh) 2002-05-29
CZ286945B6 (en) 2000-08-16
JP3818541B2 (ja) 2006-09-06
HRP950537A2 (en) 1997-08-31
NO972017L (no) 1997-04-30
NO308035B1 (no) 2000-07-10
US5552399A (en) 1996-09-03
JPH10508308A (ja) 1998-08-18
BR9509552A (pt) 1997-09-16
ES2155898T3 (es) 2001-06-01
GR3035680T3 (en) 2001-06-29
IL115819A (en) 1998-10-30
CA2203661A1 (en) 1996-05-17
AU3924995A (en) 1996-05-31
AU704285B2 (en) 1999-04-15
KR100392060B1 (ko) 2003-11-28
HUT77408A (hu) 1998-04-28
NZ295656A (en) 1998-10-28
PL319939A1 (en) 1997-09-01
FI971854A0 (fi) 1997-04-30
TW349950B (en) 1999-01-11
SI0789701T1 (en) 2001-08-31
DE69520070T2 (de) 2001-09-13
TR199501356A2 (tr) 1996-06-21
NO972017D0 (no) 1997-04-30
DK0789701T3 (da) 2001-06-18

Similar Documents

Publication Publication Date Title
ATE191211T1 (de) 3-pyrazolcarboxamidderivate mit cannabinoidrezeptor-affinität
DE69928945D1 (de) 4,4-biarylpiperidinederivate mit opioid-receptor-wirkung
ITMI930699A0 (it) Nuovi derivati dell'indolo
FI944970A7 (fi) Trisyklisiä pyrrolijohdannaisia
FI953827L (fi) Trisyklisiä pyratsolijohdannaisia
DE69637369D1 (de) Trizyclische benzazepin-vasopressin-antagoniste
AP2000001784A0 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
NO304693B1 (no) Kinoksalinderivater med affinitet for quisqualatreseptorer
FI943941L (fi) CCK-reseptoriantagonisteina käyttökelpoiset bentsodiatsepiinijohdannaiset
FI940229A7 (fi) Trisykliset kondensoituneet heterosykliset yhdisteet, niiden valmistus ja käyttö
FI20002725A7 (fi) 2,5-diokso-2,5-dihydro-1Hbents[b]atsepiinit NMDA-reseptorin antagonisteina
HU9300488D0 (en) Tricyclic benzodiazepine derivatives
NO982843D0 (no) 2,7-Substituerte oktahydro-pyrrol£1,2-a|pyrazin-derivater
DE69520070D1 (de) Substituierte tetracyclische azepinederivate mit 5-ht2 rezeptoraffinität
FI943808L (fi) Triatsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vastavaikuttajina
DE59803512D1 (de) Anhänger mit verriegelbarem bügel
FI971855A7 (fi) Substituoituja tetrasyklisiä oksatsepiini- ja tiatsepiinijohdannaisia, joilla on 5-HT2-reseptoraffineetti
FI961199A7 (fi) Substituoidut tiatsolo(3,2-alfa)atsepiinijohdannaiset
ITMI951669A1 (it) Derivati tetraciclici spiro-condensati
ITMI941649A0 (it) Derivati tetraciclici spiro-condensati
BR7600306U (pt) Pista tubular com looping vertical

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee